
Boehringer Ingelheim
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Description
Boehringer Ingelheim is a group of pharmaceutical companies that focuses on prescription medicines and animal health.
Investor Profile
Boehringer Ingelheim has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 44% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Undisclosed, Series B rounds (top funding stages).
- Majority of deals are located in United States, Kenya, Austria.
- Strong thematic focus on Health Care, Biotechnology, Medical.
Stage Focus
- Series C (22%)
- Undisclosed (11%)
- Series B (11%)
- Debt Financing (11%)
- Corporate Round (11%)
- Grant (11%)
- Post Ipo Equity (11%)
- Series A (11%)
Country Focus
- United States (44%)
- Kenya (11%)
- Austria (11%)
- Switzerland (11%)
- Canada (11%)
- Belgium (11%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Pharmaceutical
- Medical Device
- Telehealth
- Veterinary
- Electronic Health Record (Ehr)
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Boehringer Ingelheim frequently co-invest with?
What are some of recent deals done by Boehringer Ingelheim?
Find More Investors Like Boehringer Ingelheim
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








